In February 2013, Grovepoint, a private investment company, acquired a majority stake in US$50 million valued Algatechnologies Ltd., a leading manufacturer of natural astaxanthin (AstaPure). “Algatech is a company with a very interesting technology. We felt that we could bring this to the world with the added value niche product of astaxanthin. The fact that this company could succeed in producing this product in the worst conditions in the world, in the middle of the desert, gives us a lot of confidence in the strength of this technology and the people behind it,” says Hugai Stadler, CEO of Grovepoint.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder















